I don't want a take out under $65 USD
AMCO will do at least $150M in Q1, Cxr US will do $75M (due to issues already identified by mgmt. -- go forward run rate is $81M). Shorts may continue to twist and spread mis-information but pharma continues to strive. Look and Merck and Pfizer earnings and bump in guidance. Add growth through 2016 and you hit guidance as per mgmt. If CXR remains public, one year from now post US elections we will be trading at least $100 CAD. I can wait...don't sell out to this bs. GLTA.